Bright Minds Biosciences earnings release, October 2, 2026

Bright Minds Biosciences Inc. (DRUG) · Form 6-K · Filed · SEC filing

REPORT OF VOTING RESULTS

Pursuant to Section 11.3 of National Instrument 51-102 -

Continuous Disclosure Obligations, the following is the report on voting results for the annual general meeting of shareholders of Bright Minds Biosciences Inc. ("the

Company

") held on March 31, 2026 (the "

Meeting

").

The Company reports that a total of 7,877,637 common shares were voted at the Meeting, representing 80.49% of the votes attached to the common shares outstanding as of the record date for the Meeting. Voting results on the resolutions were as follows:

1.

Election of Directors

The six nominees for election to the Board of Directors received votes as follows.

2.

Appointment of Auditors

De Visser Gray LLP, Chartered Professional Accountants, were appointed as the auditor of the Company. Shares voted in person and by proxy represented 7,872,821 votes FOR, being 99.94% and 4,816 votes WITHHELD, being 0.06%.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.